{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:02:35Z","timestamp":1791288155675,"version":"4.3.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic wasting disease (CWD) is an emerging infectious prion disorder that is spreading rapidly in wild populations of cervids in North America. The risk of zoonotic transmission of CWD is as yet unclear but a high priority must be to minimize further spread of the disease. No simple diagnostic tests are available to detect CWD quickly or in live animals; therefore, easily accessible biomarkers may be useful in identifying infected animals. MicroRNAs (miRNAs) are a class of small, non-coding RNA molecules that circulate in blood and are promising biomarkers for several infectious diseases. In this study we used next-generation sequencing to characterize the serum miRNA profiles of 35 naturally infected elk that tested positive for CWD in addition to 35 elk that tested negative for CWD. A total of 21 miRNAs that are highly conserved amongst mammals were altered in abundance in sera, irrespective of hemolysis in the samples. A number of these miRNAs have previously been associated with prion diseases. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the discriminative potential of these miRNAs as biomarkers for the diagnosis of CWD. We also determined that a subgroup of 6 of these miRNAs were consistently altered in abundance in serum from hamsters experimentally infected with scrapie. This suggests that common miRNA candidate biomarkers could be selected for prion diseases in multiple species. Furthermore, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses pointed to a strong correlation for 3 of these miRNAs, miR-148a-3p, miR-186-5p, miR-30e-3p, with prion disease.<\/jats:p>","DOI":"10.1038\/s41598-019-56249-6","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T11:02:42Z","timestamp":1577098962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Jessy A.","family":"Slota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Coulthart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pritzkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"56249_CR1","doi-asserted-by":"publisher","first-page":"e1006619","DOI":"10.1371\/journal.ppat.1006619","volume":"13","author":"S Hannaoui","year":"2017","unstructured":"Hannaoui, S., Schatzl, H. M. & Gilch, S. Chronic wasting disease: Emerging prions and their potential risk. PLOS Pathog. 13, e1006619 (2017).","journal-title":"PLOS Pathog."},{"key":"56249_CR2","unstructured":"NWHC. Expanding Distribution of Chronic Wasting Disease. Available at, https:\/\/www.usgs.gov\/centers\/nwhc\/science\/expanding-distribution-chronic-wasting-disease?qt-science_center_objects=0#qt-science_center_objects."},{"key":"56249_CR3","doi-asserted-by":"publisher","unstructured":"Whitechurch, B. C., Welton, J. M., Collins, S. J. & Lawson, V. A. Prion Diseases. In Neurodegenerative Diseases, Advances in Neurobiology 335\u2013364, https:\/\/doi.org\/10.1201\/978131515235 (Springer, Cham, 2017).","DOI":"10.1201\/978131515235"},{"key":"56249_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.pmbts.2017.06.014","volume":"150","author":"A Mar\u00edn-Moreno","year":"2017","unstructured":"Mar\u00edn-Moreno, A., Fern\u00e1ndez-Borges, N., Espinosa, J. C., Andr\u00e9oletti, O. & Torres, J. M. Transmission and Replication of Prions. Prog. Mol. Biol. Transl. Sci. 150, 181\u2013201 (2017).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"56249_CR5","first-page":"60","volume-title":"Pathog. (Basel, Switzerland)","author":"NA Mabbott","year":"2017","unstructured":"Mabbott, N. A. How do PrPSc Prions Spread between Host Species, and within Hosts? Pathog. (Basel, Switzerland) 6, 60 (2017)."},{"key":"56249_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/pathogens6040063","volume":"6","author":"D Hughes","year":"2017","unstructured":"Hughes, D. & Halliday, M. What Is Our Current Understanding of PrPSc-Associated Neurotoxicity and Its Molecular Underpinnings? Pathogens 6, 63 (2017).","journal-title":"Pathogens"},{"key":"56249_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1146\/annurev-animal-022114-111001","volume":"3","author":"NJ Haley","year":"2015","unstructured":"Haley, N. J. & Hoover, E. A. Chronic Wasting Disease of Cervids: Current Knowledge and Future Perspectives. Annu. Rev. Anim. Biosci. 3, 305\u2013325 (2015).","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"56249_CR8","doi-asserted-by":"publisher","first-page":"a024448","DOI":"10.1101\/cshperspect.a024448","volume":"8","author":"JA Moreno","year":"2018","unstructured":"Moreno, J. A. & Telling, G. C. Molecular Mechanisms of Chronic Wasting Disease Prion Propagation. Cold Spring Harb. Perspect. Med. 8, a024448 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"56249_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.01091-19","volume":"10","author":"MT Osterholm","year":"2019","unstructured":"Osterholm, M. T. et al. Chronic Wasting Disease in Cervids: Implications for Prion Transmission to Humans and Other Animal Species. MBio 10, 1\u20138 (2019).","journal-title":"MBio"},{"key":"56249_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/vr.155.10.295","volume":"155","author":"TR Spraker","year":"2004","unstructured":"Spraker, T. R., Balachandran, A., Zhuang, D. & O\u2019Rourke, K. I. Variable patterns of distribution of PrP(CWD) in the obex and cranial lymphoid tissues of Rocky Mountain elk (Cervus elaphus nelsoni) with subclinical chronic wasting disease. Vet. Rec. 155, 295\u2013302 (2004).","journal-title":"Vet. Rec."},{"key":"56249_CR11","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1099\/vir.0.81999-0","volume":"87","author":"KA Fox","year":"2006","unstructured":"Fox, K. A., Jewell, J. E., Williams, E. S. & Miller, M. W. Patterns of PrPCWD accumulation during the course of chronic wasting disease infection in orally inoculated mule deer (Odocoileus hemionus). J. Gen. Virol. 87, 3451\u201361 (2006).","journal-title":"J. Gen. Virol."},{"key":"56249_CR12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio, G. P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810\u2013813 (2001).","journal-title":"Nature"},{"key":"56249_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nmeth0308-211","volume":"5","author":"R Atarashi","year":"2008","unstructured":"Atarashi, R. et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods 5, 211\u2013212 (2008).","journal-title":"Nat. Methods"},{"key":"56249_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/pathogens6030035","volume":"6","author":"N Haley","year":"2017","unstructured":"Haley, N. & Richt, J. Evolution of Diagnostic Tests for Chronic Wasting Disease, a Naturally Occurring Prion Disease of Cervids. Pathogens 6, 35 (2017).","journal-title":"Pathogens"},{"key":"56249_CR15","doi-asserted-by":"publisher","first-page":"e4848","DOI":"10.1371\/journal.pone.0004848","volume":"4","author":"NJ Haley","year":"2009","unstructured":"Haley, N. J., Seelig, D. M., Zabel, M. D., Telling, G. C. & Hoover, E. A. Detection of CWD Prions in Urine and Saliva of Deer by Transgenic Mouse Bioassay. PLoS One 4, e4848 (2009).","journal-title":"PLoS One"},{"key":"56249_CR16","doi-asserted-by":"publisher","first-page":"e7990","DOI":"10.1371\/journal.pone.0007990","volume":"4","author":"NJ Haley","year":"2009","unstructured":"Haley, N. J., Mathiason, C. K., Zabel, M. D., Telling, G. C. & Hoover, E. A. Detection of Sub-Clinical CWD Infection in Conventional Test-Negative Deer Long after Oral Exposure to Urine and Feces from CWD+ Deer. PLoS One 4, e7990 (2009).","journal-title":"PLoS One"},{"key":"56249_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1126\/science.1132661","volume":"314","author":"CK Mathiason","year":"2006","unstructured":"Mathiason, C. K. et al. Infectious Prions in the Saliva and Blood of Deer with Chronic Wasting Disease. Science (80-.). 314, 133\u2013136 (2006).","journal-title":"Science (80-.)."},{"key":"56249_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature08289","volume":"461","author":"G Tamg\u00fcney","year":"2009","unstructured":"Tamg\u00fcney, G. et al. Asymptomatic deer excrete infectious prions in faeces. Nature 461, 529\u2013532 (2009).","journal-title":"Nature"},{"key":"56249_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17090-x","volume":"7","author":"C Kramm","year":"2017","unstructured":"Kramm, C. et al. Detection of Prions in Blood of Cervids at the Asymptomatic Stage of Chronic Wasting Disease. Sci. Rep. 7, 17241 (2017).","journal-title":"Sci. Rep."},{"key":"56249_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","volume":"87","author":"SM Hammond","year":"2015","unstructured":"Hammond, S. M. An overview of microRNAs. Adv. Drug Deliv. Rev. 87, 3\u201314 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"56249_CR21","doi-asserted-by":"crossref","unstructured":"Vishnoi, A. & Rani, S. MiRNA Biogenesis and Regulation of Diseases: An Overview. In Methods in Molecular Biology 1509, 1\u201310 (2017).","DOI":"10.1007\/978-1-4939-6524-3_1"},{"key":"56249_CR22","doi-asserted-by":"publisher","first-page":"e1006802","DOI":"10.1371\/journal.ppat.1006802","volume":"14","author":"F Llorens","year":"2018","unstructured":"Llorens, F. et al. Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis. PLoS Pathog. 14, e1006802 (2018).","journal-title":"PLoS Pathog."},{"key":"56249_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1326-4-36","volume":"4","author":"J Montag","year":"2009","unstructured":"Montag, J. et al. Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol. Neurodegener. 4, 36 (2009).","journal-title":"Mol. Neurodegener."},{"key":"56249_CR24","doi-asserted-by":"publisher","first-page":"e1003002","DOI":"10.1371\/journal.ppat.1003002","volume":"8","author":"A Majer","year":"2012","unstructured":"Majer, A. et al. Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog. 8, e1003002 (2012).","journal-title":"PLoS Pathog."},{"key":"56249_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mcn.2015.12.001","volume":"71","author":"AS Boese","year":"2016","unstructured":"Boese, A. S. et al. MicroRNA abundance is altered in synaptoneurosomes during prion disease. Mol. Cell. Neurosci. 71, 13\u201324 (2016).","journal-title":"Mol. Cell. Neurosci."},{"key":"56249_CR26","doi-asserted-by":"publisher","first-page":"e3652","DOI":"10.1371\/journal.pone.0003652","volume":"3","author":"R Saba","year":"2008","unstructured":"Saba, R., Goodman, C. D., Huzarewich, R. L. C. H., Robertson, C. & Booth, S. A. A miRNA Signature of Prion Induced Neurodegeneration. PLoS One 3, e3652 (2008).","journal-title":"PLoS One"},{"key":"56249_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-486","volume":"13","author":"J Montag","year":"2012","unstructured":"Montag, J. et al. A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasis. BMC Genomics 13, 486 (2012).","journal-title":"BMC Genomics"},{"key":"56249_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2016.120","volume":"5","author":"C Gao","year":"2016","unstructured":"Gao, C. et al. MiRNA expression profiles in the brains of mice infected with scrapie agents 139A, ME7 and S15. Emerg. Microbes Infect. 5, 1\u201310 (2016).","journal-title":"Emerg. Microbes Infect."},{"key":"56249_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnagi.2018.00220","volume":"10","author":"E Kanata","year":"2018","unstructured":"Kanata, E. et al. MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives. Front. Aging Neurosci. 10, 220 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"56249_CR30","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1080\/15287394.2011.618973","volume":"74","author":"WJ Lukiw","year":"2011","unstructured":"Lukiw, W. J., Dua, P., Pogue, A. I., Eicken, C. & Hill, J. M. Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J. Toxicol. Environ. Health. A 74, 1460\u20138 (2011).","journal-title":"J. Toxicol. Environ. Health. A"},{"key":"56249_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/bpa.12679","volume":"29","author":"D Pease","year":"2019","unstructured":"Pease, D. et al. Genome-wide identification of microRNAs regulating the human prion protein. Brain Pathol. 29, 232\u2013244 (2019).","journal-title":"Brain Pathol."},{"key":"56249_CR32","doi-asserted-by":"publisher","first-page":"e0167969","DOI":"10.1371\/journal.pone.0167969","volume":"12","author":"C Glinge","year":"2017","unstructured":"Glinge, C. et al. Stability of Circulating Blood-Based MicroRNAs \u2013 Pre-Analytic Methodological Considerations. PLoS One 12, e0167969 (2017).","journal-title":"PLoS One"},{"key":"56249_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1099\/jgv.0.000685","volume":"98","author":"D Sanz Rubio","year":"2017","unstructured":"Sanz Rubio, D. et al. Increased circulating microRNAs miR-342-3p and miR-21-5p in natural sheep prion disease. J. Gen. Virol. 98, 305\u2013310 (2017).","journal-title":"J. Gen. Virol."},{"key":"56249_CR34","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.3390\/molecules19056891","volume":"19","author":"M Grasso","year":"2014","unstructured":"Grasso, M., Piscopo, P., Confaloni, A. & Denti, M. Circulating miRNAs as Biomarkers for Neurodegenerative Disorders. Molecules 19, 6891\u20136910 (2014).","journal-title":"Molecules"},{"key":"56249_CR35","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-160835","volume":"55","author":"TA Lusardi","year":"2016","unstructured":"Lusardi, T. A. et al. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer\u2019s Disease. J. Alzheimer\u2019s Dis. 55, 1223\u20131233 (2016).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"56249_CR36","first-page":"1241","volume":"48","author":"CK Argue","year":"2007","unstructured":"Argue, C. K., Ribble, C., Lees, V. W., McLane, J. & Balachandran, A. Epidemiology of an outbreak of chronic wasting disease on elk farms in Saskatchewan. Can. Vet. J. 48, 1241\u20138 (2007).","journal-title":"Can. Vet. J."},{"key":"56249_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10 (2011).","journal-title":"EMBnet.journal"},{"key":"56249_CR38","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"56249_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"56249_CR40","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"56249_CR41","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara, A. & Griffiths-Jones, S. MiRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42, D68\u2013D73 (2014).","journal-title":"Nucleic Acids Res."},{"key":"56249_CR42","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara, A., Birgaoanu, M. & Griffiths-Jones, S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 47, D155\u2013D162 (2019).","journal-title":"Nucleic Acids Res."},{"key":"56249_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"56249_CR44","doi-asserted-by":"publisher","first-page":"e0153200","DOI":"10.1371\/journal.pone.0153200","volume":"11","author":"JS Shah","year":"2016","unstructured":"Shah, J. S., Soon, P. S. & Marsh, D. J. Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs. PLoS One 11, e0153200 (2016).","journal-title":"PLoS One"},{"key":"56249_CR45","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps. R package version 1.0.8 (2015)."},{"key":"56249_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"56249_CR47","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing, T., Sander, O., Beerenwinkel, N. & Lengauer, T. ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940\u20133941 (2005).","journal-title":"Bioinformatics"},{"key":"56249_CR48","doi-asserted-by":"publisher","first-page":"W460","DOI":"10.1093\/nar\/gkv403","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos, I. S. et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 43, W460\u2013W466 (2015).","journal-title":"Nucleic Acids Res."},{"key":"56249_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"56249_CR50","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K. & Tanabe, M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47, D590\u2013D595 (2019).","journal-title":"Nucleic Acids Res."},{"key":"56249_CR51","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"56249_CR52","doi-asserted-by":"publisher","first-page":"D146","DOI":"10.1093\/nar\/gku1104","volume":"43","author":"N Wong","year":"2015","unstructured":"Wong, N. & Wang, X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 43, D146\u2013D152 (2015).","journal-title":"Nucleic Acids Res."},{"key":"56249_CR53","doi-asserted-by":"crossref","unstructured":"Agarwal, V., Bell, G. W., Nam, J.-W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife 4 (2015).","DOI":"10.7554\/eLife.05005"},{"key":"56249_CR54","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht, C., De La Torre, C., Parveen, A. & Gretz, N. miRWalk: An online resource for prediction of microRNA binding sites. PLoS One 13, e0206239 (2018).","journal-title":"PLoS One"},{"key":"56249_CR55","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gkx1141","volume":"46","author":"D Karagkouni","year":"2018","unstructured":"Karagkouni, D. et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA\u2013gene interactions. Nucleic Acids Res. 46, D239\u2013D245 (2018).","journal-title":"Nucleic Acids Res."},{"key":"56249_CR56","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"56249_CR57","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"56249_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"56249_CR59","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen, C. L., Jensen, J. L. & \u00d8rntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64, 5245\u201350 (2004).","journal-title":"Cancer Res."},{"key":"56249_CR60","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","volume":"59","author":"T Blondal","year":"2013","unstructured":"Blondal, T. et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59, S1\u2013S6 (2013).","journal-title":"Methods"},{"key":"56249_CR61","first-page":"1","volume":"4","author":"MB Kirschner","year":"2013","unstructured":"Kirschner, M. B. et al. The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Front. Genet. 4, 1\u201313 (2013).","journal-title":"Front. Genet."},{"key":"56249_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12917-018-1400-9","volume":"14","author":"SJ Moore","year":"2018","unstructured":"Moore, S. J. et al. Pathologic and biochemical characterization of PrPSc from elk with PRNP polymorphisms at codon 132 after experimental infection with the chronic wasting disease agent. BMC Vet. Res. 14, 80 (2018).","journal-title":"BMC Vet. Res."},{"key":"56249_CR63","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1099\/vir.0.83168-0","volume":"89","author":"KM Green","year":"2008","unstructured":"Green, K. M. et al. The elk PRNP codon 132 polymorphism controls cervid and scrapie prion propagation. J. Gen. Virol. 89, 598\u2013608 (2008).","journal-title":"J. Gen. Virol."},{"key":"56249_CR64","doi-asserted-by":"publisher","first-page":"e94839","DOI":"10.1371\/journal.pone.0094839","volume":"9","author":"K Burgos","year":"2014","unstructured":"Burgos, K. et al. Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer\u2019s and Parkinson\u2019s Diseases Correlate with Disease Status and Features of Pathology. PLoS One 9, e94839 (2014).","journal-title":"PLoS One"},{"key":"56249_CR65","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-140756","volume":"42","author":"D Galimberti","year":"2014","unstructured":"Galimberti, D. et al. Circulating miRNAs as Potential Biomarkers in Alzheimer\u2019s Disease. J. Alzheimer\u2019s Dis. 42, 1261\u20131267 (2014).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"56249_CR66","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/cbf.3184","volume":"34","author":"L-H Jia","year":"2016","unstructured":"Jia, L.-H. & Liu, Y.-N. Downregulated serum miR-223 servers as biomarker in Alzheimer\u2019s disease. Cell Biochem. Funct. 34, 233\u2013237 (2016).","journal-title":"Cell Biochem. Funct."},{"key":"56249_CR67","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-130932","volume":"39","author":"T Kiko","year":"2014","unstructured":"Kiko, T. et al. MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer\u2019s Disease. J. Alzheimer\u2019s Dis. 39, 253\u2013259 (2014).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"56249_CR68","doi-asserted-by":"publisher","first-page":"e0139233","DOI":"10.1371\/journal.pone.0139233","volume":"10","author":"G Lugli","year":"2015","unstructured":"Lugli, G. et al. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. PLoS One 10, e0139233 (2015).","journal-title":"PLoS One"},{"key":"56249_CR69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","volume":"336","author":"L Tan","year":"2014","unstructured":"Tan, L. et al. Circulating miR-125b as a biomarker of Alzheimer\u2019s disease. J. Neurol. Sci. 336, 52\u201356 (2014).","journal-title":"J. Neurol. Sci."},{"key":"56249_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger, P. et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 14, R78 (2013).","journal-title":"Genome Biol."},{"key":"56249_CR71","doi-asserted-by":"publisher","first-page":"BMI.S25132","DOI":"10.4137\/BMI.S25132","volume":"10","author":"J Satoh","year":"2015","unstructured":"Satoh, J., Kino, Y. & Niida, S. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer\u2019s Disease from Public Data. Biomark. Insights 10, BMI.S25132 (2015).","journal-title":"Biomark. Insights"},{"key":"56249_CR72","doi-asserted-by":"publisher","first-page":"GRSB.S361","DOI":"10.4137\/GRSB.S361","volume":"1","author":"HM Schipper","year":"2007","unstructured":"Schipper, H. M., Maes, O. C., Chertkow, H. M. & Wang, E. MicroRNA Expression in Alzheimer Blood Mononuclear Cells. Gene Regul. Syst. Bio. 1, GRSB.S361 (2007).","journal-title":"Gene Regul. Syst. Bio."},{"key":"56249_CR73","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4088\/JCP.13m08812","volume":"76","author":"T Wang","year":"2015","unstructured":"Wang, T. et al. The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment. J. Clin. Psychiatry 76, 135\u201341 (2015).","journal-title":"J. Clin. Psychiatry"},{"key":"56249_CR74","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1089\/omi.2016.0099","volume":"20","author":"\u015eG Y\u0131lmaz","year":"2016","unstructured":"Y\u0131lmaz, \u015e. G., Erdal, M. E., \u00d6zge, A. A. & Sungur, M. A. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer\u2019s Disease? Omi. A J. Integr. Biol. 20, 456\u2013461 (2016).","journal-title":"Omi. A J. Integr. Biol."},{"key":"56249_CR75","doi-asserted-by":"publisher","first-page":"16122","DOI":"10.18632\/oncotarget.15109","volume":"8","author":"S Nagaraj","year":"2017","unstructured":"Nagaraj, S. et al. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer\u2019s disease patients from non-demented subjects. Oncotarget 8, 16122\u201316143 (2017).","journal-title":"Oncotarget"},{"key":"56249_CR76","first-page":"1","volume":"2015","author":"H Dong","year":"2015","unstructured":"Dong, H. et al. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer\u2019s Disease. Dis. Markers 2015, 1\u201311 (2015).","journal-title":"Dis. Markers"},{"key":"56249_CR77","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1007\/s12035-016-0088-8","volume":"54","author":"M Cos\u00edn-Tom\u00e1s","year":"2017","unstructured":"Cos\u00edn-Tom\u00e1s, M. et al. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer\u2019s Disease: Potential and Limitations. Mol. Neurobiol. 54, 5550\u20135562 (2017).","journal-title":"Mol. Neurobiol."},{"key":"56249_CR78","doi-asserted-by":"publisher","first-page":"e69807","DOI":"10.1371\/journal.pone.0069807","volume":"8","author":"P Kumar","year":"2013","unstructured":"Kumar, P. et al. Circulating miRNA Biomarkers for Alzheimer\u2019s Disease. PLoS One 8, e69807 (2013).","journal-title":"PLoS One"},{"key":"56249_CR79","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.expneurol.2011.11.026","volume":"235","author":"H Geekiyanage","year":"2012","unstructured":"Geekiyanage, H., Jicha, G. A., Nelson, P. T. & Chan, C. Blood serum miRNA: Non-invasive biomarkers for Alzheimer\u2019s disease. Exp. Neurol. 235, 491\u2013496 (2012).","journal-title":"Exp. Neurol."},{"key":"56249_CR80","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-132144","volume":"40","author":"L Tan","year":"2014","unstructured":"Tan, L. et al. Genome-Wide Serum microRNA Expression Profiling Identifies Serum Biomarkers for Alzheimer\u2019s Disease. J. Alzheimer\u2019s Dis. 40, 1017\u20131027 (2014).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"56249_CR81","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.12659\/MSM.905064","volume":"23","author":"W-S Chang","year":"2017","unstructured":"Chang, W.-S., Wang, Y.-H., Zhu, X.-T. & Wu, C.-J. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer\u2019s Disease. Med. Sci. Monit. 23, 2721\u20132731 (2017).","journal-title":"Med. Sci. Monit."},{"key":"56249_CR82","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1212\/WNL.0000000000001258","volume":"84","author":"A Serafin","year":"2015","unstructured":"Serafin, A. et al. Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD. Neurology 84, 645\u2013653 (2015).","journal-title":"Neurology"},{"key":"56249_CR83","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnagi.2016.00017","volume":"8","author":"P Piscopo","year":"2016","unstructured":"Piscopo, P., Albani, D., Castellano, A. E., Forloni, G. & Confaloni, A. Frontotemporal Lobar Degeneration and MicroRNAs. Front. Aging Neurosci. 8, 17 (2016).","journal-title":"Front. Aging Neurosci."},{"key":"56249_CR84","doi-asserted-by":"publisher","first-page":"334","DOI":"10.2353\/ajpath.2010.091202","volume":"177","author":"WX Wang","year":"2010","unstructured":"Wang, W. X. et al. miR-107 regulates granulin\/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 177, 334\u2013345 (2010).","journal-title":"Am. J. Pathol."},{"key":"56249_CR85","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1007\/s12035-016-0002-4","volume":"54","author":"S Moncini","year":"2017","unstructured":"Moncini, S. et al. The miR-15\/107 Family of microRNA Genes Regulates CDK5R1\/p35 with Implications for Alzheimer\u2019s Disease Pathogenesis. Mol. Neurobiol. 54, 4329\u20134342 (2017).","journal-title":"Mol. Neurobiol."},{"key":"56249_CR86","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1567205016666181212154347","volume":"16","author":"W Hu","year":"2019","unstructured":"Hu, W., Wen, L., Cao, F. & Wang, Y. Down-Regulation of Mir-107 Worsen Spatial Memory by Suppressing SYK Expression and Inactivating NF-\u039aB Signaling Pathway. Curr. Alzheimer Res. 16, 135\u2013145 (2019).","journal-title":"Curr. Alzheimer Res."},{"key":"56249_CR87","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","volume":"28","author":"W-X Wang","year":"2008","unstructured":"Wang, W.-X. et al. The Expression of MicroRNA miR-107 Decreases Early in Alzheimer\u2019s Disease and May Accelerate Disease Progression through Regulation of -Site Amyloid Precursor Protein-Cleaving Enzyme 1. J. Neurosci. 28, 1213\u20131223 (2008).","journal-title":"J. Neurosci."},{"key":"56249_CR88","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fnagi.2015.00210","volume":"7","author":"X Ye","year":"2015","unstructured":"Ye, X. et al. MicroRNAs 99b-5p\/100-5p Regulated by Endoplasmic Reticulum Stress are Involved in Abeta-Induced Pathologies. Front. Aging Neurosci. 7, 210 (2015).","journal-title":"Front. Aging Neurosci."},{"key":"56249_CR89","doi-asserted-by":"publisher","first-page":"e0126423","DOI":"10.1371\/journal.pone.0126423","volume":"10","author":"J Denk","year":"2015","unstructured":"Denk, J. et al. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer\u2019s Disease. PLoS One 10, e0126423 (2015).","journal-title":"PLoS One"},{"key":"56249_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-33","volume":"13","author":"YK Adlakha","year":"2014","unstructured":"Adlakha, Y. K. & Saini, N. Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol. Cancer 13, 33 (2014).","journal-title":"Mol. Cancer"},{"key":"56249_CR91","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4161\/pri.27381","volume":"7","author":"K Uchiyama","year":"2013","unstructured":"Uchiyama, K., Miyata, H. & Sakaguchi, S. Disturbed vesicular trafficking of membrane proteins in prion disease. Prion 7, 447\u2013451 (2013).","journal-title":"Prion"},{"key":"56249_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2873","volume":"4","author":"K Uchiyama","year":"2013","unstructured":"Uchiyama, K. et al. Prions disturb post-Golgi trafficking of membrane proteins. Nat. Commun. 4, 1846 (2013).","journal-title":"Nat. Commun."},{"key":"56249_CR93","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00401-015-1508-y","volume":"131","author":"C McKinnon","year":"2016","unstructured":"McKinnon, C. et al. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin\u2013proteasome system. Acta Neuropathol. 131, 411\u2013425 (2016).","journal-title":"Acta Neuropathol."},{"key":"56249_CR94","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/abbs\/gmt020","volume":"45","author":"Z Lin","year":"2013","unstructured":"Lin, Z., Zhao, D. & Yang, L. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration. Acta Biochim. Biophys. Sin. (Shanghai). 45, 477\u2013484 (2013).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)."},{"key":"56249_CR95","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/1040638715593368","volume":"27","author":"TR Spraker","year":"2015","unstructured":"Spraker, T. R. et al. Progressive accumulation of the abnormal conformer of the prion protein and spongiform encephalopathy in the obex of nonsymptomatic and symptomatic Rocky Mountain elk (Cervus elaphus nelsoni) with chronic wasting disease. J. Vet. Diagnostic Investig. 27, 431\u2013441 (2015).","journal-title":"J. Vet. Diagnostic Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56249-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56249-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56249-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:57:10Z","timestamp":1671299830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56249-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,23]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56249"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56249-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,23]]},"assertion":[{"value":"23 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Soto is inventor on several patents related to the PMCA technology and is currently Founder, Chief Scientific Officer and member of the Board of Directors of Amprion Inc, a biotech company focusing on the commercial utilization of PMCA and RT-QuIC for prion diagnosis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19705"}}